Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

BIT225 COVID-19 Human Study Commenced

14 September 2022 by Audrey Thomson

BIT225 COVID-19 Human Study Commenced

Categories 2022, ASX Announcements

BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited

Second BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 25 September 2024 Legal Notices and Privacy